Trebananib Completed Phase 1 Trials for Fallopian Tube Cancer / Carcinoma NOS / Primary Peritoneal Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01253681Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer